Incidence of pediatric, adolescent and young adult head and neck melanoma is up 51 percent
Head and neck melanoma among pediatric, adolescent and young adult populations in the United States and Canada increased by 51.1% from 1995 to 2014.
Read moreHead and neck melanoma among pediatric, adolescent and young adult populations in the United States and Canada increased by 51.1% from 1995 to 2014.
Read moreDistinct patterns of electrical activity in the sleeping brain may influence whether we remember or forget what we learned the previous day, according to a new study. The scientists were able to influence how well rats learned a new skill by tweaking these brainwaves while animals slept, suggesting potential future applications in boosting human memory or forgetting traumatic experiences, the researchers say.
Read moreThe study details the nature of the injury, specifies the brain regions involved, including the blood-brain barrier and suggests a possible cause in the form of 'cholinesterase inhibitors,' with 'organophosphorus insecticides' being a likely source. Cholinesterase (ChE) is one of the key enzymes required for the proper functioning of the nervous systems of humans, invertebrates and insects.
Read moreA research team has discovered a metabolic vulnerability in multiple types of cancer cells that bear a common genetic mutation affecting cellular machines called spliceosomes.
Read moreTwo very different mutations have been identified as unexpected partners in crime for causing the blood cancer acute myeloid leukemia (AML). Expert analysis from CSHL helped reveal how this deadly duo is far more common in AML than thought.
Read moreYoung adults who experience annual income drops of 25% or more may be more at risk of having thinking problems and reduced brain health in middle age, according to a new study.
Read moreA new 3D structure for growing cell cultures could enable doctors to test medications on model tumors grown from a patient's own cells, according to a team of engineers and cancer researchers.
Read morePhorbiplatin is a new anti-cancer prodrug that can be controllably activated by red light. With its unique 'on-site' activation characteristic, this new prodrug can effectively kill cancer cells and minimize damage to normal tissues.
Read moreA study in mice showed that reducing a particular hormone signal keeps the cancer from growing and spreading.
Read moreA new study finds that a form of immunotherapy used to treat the blood cancer leukemia may be effective in treating other kinds of cancer as well.
Read more